instruction stringlengths 34 186 | input stringlengths 2.02k 93.8k | output stringlengths 2 418 | meta_questiontype stringclasses 6
values | meta_inputlicense stringclasses 6
values | meta_pmid stringlengths 8 8 | meta_safetyreportid int64 9.51M 21M | meta_articlepubdate stringlengths 4 10 |
|---|---|---|---|---|---|---|---|
What was the administration route of drug 'SUCCINYLCHOLINE CHLORIDE'? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
What was the dosage of drug 'PROPOFOL'? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | 10 MG/KG/H | DrugDosageText | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
What was the dosage of drug 'REMIFENTANIL'? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | RATE OF REMIFENTANIL INFUSION WAS INCREASED TO 0.5 UG/KG/MIN BEFORE THE SURGERY | DrugDosageText | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
What was the outcome of reaction 'Arteriospasm coronary'? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | Recovered | ReactionOutcome | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
What was the outcome of reaction 'Atrioventricular block'? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | Recovered | ReactionOutcome | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
What was the outcome of reaction 'Electrocardiogram ST segment elevation'? | Complete atrio-ventricular block with coronary artery spasm due to direct laryngoscopy in a pediatric patient with laryngeal papillomatosis: a case report.
BACKGROUND
Coronary artery spasm has rarely been reported in pediatric patients. Previous studies have reported comorbidities and risk factors for coronary artery s... | Recovered | ReactionOutcome | CC BY | 33866440 | 19,728,461 | 2021-04-17 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Adrenal insufficiency'. | Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer.
Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs... | CAPECITABINE, DEXAMETHASONE, OXALIPLATIN, PALONOSETRON HYDROCHLORIDE, TISLELIZUMAB | DrugsGivenReaction | CC BY-NC | 33866751 | 19,257,534 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hypothyroidism'. | Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer.
Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs... | CAPECITABINE, DEXAMETHASONE, OXALIPLATIN, PALONOSETRON HYDROCHLORIDE, TISLELIZUMAB | DrugsGivenReaction | CC BY-NC | 33866751 | 19,257,534 | 2021-04-19 |
What was the administration route of drug 'DEXAMETHASONE'? | Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer.
Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33866751 | 19,257,534 | 2021-04-19 |
What was the administration route of drug 'PALONOSETRON HYDROCHLORIDE'? | Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer.
Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY-NC | 33866751 | 19,257,534 | 2021-04-19 |
What was the dosage of drug 'CAPECITABINE'? | Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer.
Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs... | FROM D1?D14 | DrugDosageText | CC BY-NC | 33866751 | 19,257,534 | 2021-04-19 |
What was the dosage of drug 'OXALIPLATIN'? | Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer.
Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs... | ON D1 | DrugDosageText | CC BY-NC | 33866751 | 19,257,534 | 2021-04-19 |
What was the dosage of drug 'TISLELIZUMAB'? | Adrenal insufficiency development during chemotherapy plus anti-programmed death receptor-1 monoclonal antibody (tislelizumab) therapy in patients with advanced gastric cancer.
Immune checkpoint inhibitor (ICI)-associated adrenal insufficiency is rare but may become a serious adverse event in patients treated with ICIs... | ON D1 AT 3 WEEK INTERVALS | DrugDosageText | CC BY-NC | 33866751 | 19,257,534 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Thrombocytopenia'. | Infective Endocarditis from Furuncle with Meningitis Complication Caused by Methicillin-resistant Staphylococcus aureus.
Infective endocarditis (IE) may be acquired in the community as community-acquired (CA) IE or in the healthcare setting. In Japan, cases of CA-methicillin-resistant Staphylococcus aureus (MRSA) infec... | DAPTOMYCIN, LINEZOLID | DrugsGivenReaction | CC BY-NC-ND | 33867390 | 20,453,547 | 2021-10-15 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cerebrovascular accident'. | Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
BACKGROUND The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. CASE REPORT A 57-year-old woman was diagnosed wit... | .ALPHA.-LIPOIC ACID, ACETYLCYSTEINE, CHOLECALCIFEROL, CITRULLINE, CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE HYDROCHLORIDE\RIBOFLAVIN 5^-PHOSPHATE SODIUM\THIA, INSULIN NOS, MAGNESIUM, METFORMIN HYDROCHLORIDE, NIACINAMIDE, POTASSIUM, TAURINE, UBIQUINOL | DrugsGivenReaction | CC BY-NC-ND | 33867519 | 19,944,452 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Contraindicated product administered'. | Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
BACKGROUND The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. CASE REPORT A 57-year-old woman was diagnosed wit... | .ALPHA.-LIPOIC ACID, ACETYLCYSTEINE, CHOLECALCIFEROL, CITRULLINE, CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE HYDROCHLORIDE\RIBOFLAVIN 5^-PHOSPHATE SODIUM\THIA, INSULIN NOS, MAGNESIUM, METFORMIN HYDROCHLORIDE, NIACINAMIDE, POTASSIUM, TAURINE, UBIQUINOL | DrugsGivenReaction | CC BY-NC-ND | 33867519 | 19,944,452 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Lactic acidosis'. | Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
BACKGROUND The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. CASE REPORT A 57-year-old woman was diagnosed wit... | .ALPHA.-LIPOIC ACID, ACETYLCYSTEINE, CHOLECALCIFEROL, CITRULLINE, CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE HYDROCHLORIDE\RIBOFLAVIN 5^-PHOSPHATE SODIUM\THIA, INSULIN NOS, MAGNESIUM, METFORMIN HYDROCHLORIDE, NIACINAMIDE, POTASSIUM, TAURINE, UBIQUINOL | DrugsGivenReaction | CC BY-NC-ND | 33867519 | 19,944,452 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Mitochondrial encephalomyopathy'. | Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
BACKGROUND The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. CASE REPORT A 57-year-old woman was diagnosed wit... | .ALPHA.-LIPOIC ACID, ACETYLCYSTEINE, CHOLECALCIFEROL, CITRULLINE, CYANOCOBALAMIN\DEXPANTHENOL\NIACINAMIDE\PYRIDOXINE HYDROCHLORIDE\RIBOFLAVIN 5^-PHOSPHATE SODIUM\THIA, INSULIN NOS, MAGNESIUM, METFORMIN HYDROCHLORIDE, NIACINAMIDE, POTASSIUM, TAURINE, UBIQUINOL | DrugsGivenReaction | CC BY-NC-ND | 33867519 | 19,944,452 | 2021-04-19 |
What is the weight of the patient? | Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
BACKGROUND The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. CASE REPORT A 57-year-old woman was diagnosed wit... | 56 kg. | Weight | CC BY-NC-ND | 33867519 | 19,944,452 | 2021-04-19 |
What was the dosage of drug 'METFORMIN HYDROCHLORIDE'? | Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
BACKGROUND The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. CASE REPORT A 57-year-old woman was diagnosed wit... | 2000 mg (milligrams). | DrugDosage | CC BY-NC-ND | 33867519 | 19,944,452 | 2021-04-19 |
What was the outcome of reaction 'Lactic acidosis'? | Lifestyle Changes Normalize Serum Lactate Levels in an m.3243A>G Carrier.
BACKGROUND The normalization of serum lactate levels in a patient with non-syndromic mitochondrial disorder due to the m.3243A>G mitochondrial DNA (mtDNA) variant has not been previously reported. CASE REPORT A 57-year-old woman was diagnosed wit... | Recovered | ReactionOutcome | CC BY-NC-ND | 33867519 | 19,944,452 | 2021-04-19 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant.
Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family native to South-East Asia and Australasia. It is used by locals recreationally to induce stimulant and sedative effects and medically to soothe pain an... | BUPROPION, PAROXETINE, PREGABALIN, SERTRALINE HYDROCHLORIDE, TRAMADOL, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868054 | 19,811,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Case Report: Treatment of Kratom Use Disorder With a Classical Tricyclic Antidepressant.
Kratom or Mitragyna speciosa (Korth.) is an evergreen tree of the coffee family native to South-East Asia and Australasia. It is used by locals recreationally to induce stimulant and sedative effects and medically to soothe pain an... | BUPROPION, PAROXETINE, PREGABALIN, SERTRALINE HYDROCHLORIDE, TRAMADOL, TRAZODONE HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868054 | 19,811,479 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatic failure'. | Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review.
Everolimus, an immunosuppressant, is approved for the treatment of advanced renal cell carcinoma, metastatic hormone receptor-positive breast cancer, and pancreatic neuroendocrine tumors... | EVEROLIMUS, OCTREOTIDE | DrugsGivenReaction | CC BY | 33868173 | 19,920,073 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Hepatitis B'. | Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review.
Everolimus, an immunosuppressant, is approved for the treatment of advanced renal cell carcinoma, metastatic hormone receptor-positive breast cancer, and pancreatic neuroendocrine tumors... | EVEROLIMUS, OCTREOTIDE | DrugsGivenReaction | CC BY | 33868173 | 19,920,073 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Therapeutic product effect incomplete'. | Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review.
Everolimus, an immunosuppressant, is approved for the treatment of advanced renal cell carcinoma, metastatic hormone receptor-positive breast cancer, and pancreatic neuroendocrine tumors... | EVEROLIMUS, OCTREOTIDE | DrugsGivenReaction | CC BY | 33868173 | 19,920,073 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Abortion induced'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Central nervous system immune reconstitution inflammatory response'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coma'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal exposure during pregnancy'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,587 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Foetal growth restriction'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,587 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Maternal exposure during pregnancy'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscular weakness'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,589 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Teratogenicity'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,587 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'White matter lesion'. | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | LEVETIRACETAM, MEROPENEM, VANCOMYCIN HYDROCHLORIDE | DrugsGivenReaction | CC BY | 33868222 | 19,950,589 | 2021 |
What was the administration route of drug 'LEVETIRACETAM'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | Intra-uterine | DrugAdministrationRoute | CC BY | 33868222 | 19,950,587 | 2021 |
What was the dosage of drug 'LEVETIRACETAM'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | 1 DOSAGE FORM, BID | DrugDosageText | CC BY | 33868222 | 19,950,589 | 2021 |
What was the dosage of drug 'MEROPENEM'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | 2 DOSAGE FORM, Q 8 HR | DrugDosageText | CC BY | 33868222 | 19,950,589 | 2021 |
What was the dosage of drug 'VANCOMYCIN HYDROCHLORIDE'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | 1 DOSAGE FORM, Q 8 HR | DrugDosageText | CC BY | 33868222 | 19,950,589 | 2021 |
What was the outcome of reaction 'Abortion induced'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | Recovered | ReactionOutcome | CC BY | 33868222 | 19,950,589 | 2021 |
What was the outcome of reaction 'Central nervous system immune reconstitution inflammatory response'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | Recovering | ReactionOutcome | CC BY | 33868222 | 19,950,589 | 2021 |
What was the outcome of reaction 'Coma'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | Recovered | ReactionOutcome | CC BY | 33868222 | 19,950,589 | 2021 |
What was the outcome of reaction 'Foetal growth restriction'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | Fatal | ReactionOutcome | CC BY | 33868222 | 19,950,587 | 2021 |
What was the outcome of reaction 'Muscular weakness'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | Not recovered | ReactionOutcome | CC BY | 33868222 | 19,950,589 | 2021 |
What was the outcome of reaction 'Teratogenicity'? | Case Report: Central Nervous System Immune Reconstitution Inflammatory Syndrome Related to Bacterial Meningitis.
Central nervous system immune reconstitution inflammatory syndrome (CNS-IRIS) describes clinical characteristics that may be observed in previously immunocompromised patients during rapid restoration of immu... | Fatal | ReactionOutcome | CC BY | 33868222 | 19,950,587 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Disease progression'. | Case Report: Clinical Responses to Tislelizumab as a First-Line Therapy for Primary Hepatocellular Carcinoma With B-Cell Indolent Lymphoma.
As an emerging therapy with a promising efficacy, immunotherapy has been widely used in the treatment of solid tumors and hematologic malignancies. This clinical study compares the... | EBASTINE, LORATADINE, MOMETASONE | DrugsGivenReaction | CC BY | 33868256 | 20,050,618 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease in intestine'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, DECITABINE, DOXORUBICIN, ESTAZOLAM, FLUDARABINE PHOSPHATE, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, RUXOLITINIB, TISLELIZUMAB, VINCRISTINE SULFATE, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,938,943 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Acute graft versus host disease'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, TISLELIZUMAB | DrugsGivenReaction | CC BY | 33868266 | 19,225,338 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Death'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Delirium'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective for unapproved indication'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug ineffective'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, DECITABINE, DOXORUBICIN, ESTAZOLAM, FLUDARABINE PHOSPHATE, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, RUXOLITINIB, TISLELIZUMAB, VINCRISTINE SULFATE, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,938,943 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Drug-induced liver injury'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Dystonia'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Gastrointestinal infection'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, DECITABINE, DOXORUBICIN, ESTAZOLAM, FLUDARABINE PHOSPHATE, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, RUXOLITINIB, TISLELIZUMAB, VINCRISTINE SULFATE, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,938,943 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Graft versus host disease'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, ESTAZOLAM, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,222,652 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Herpes zoster infection neurological'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Muscle strength abnormal'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Off label use'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, BUSULFAN, CYCLOPHOSPHAMIDE, CYCLOSPORINE, DECITABINE, DOXORUBICIN, ESTAZOLAM, FLUDARABINE PHOSPHATE, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISOLONE, RITUXIMAB, RUXOLITINIB, TISLELIZUMAB, VINCRISTINE SULFATE, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,938,943 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Product use in unapproved indication'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pyrexia'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Tremor'. | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | AZACITIDINE, BASILIXIMAB, CYCLOSPORINE, ESTAZOLAM, METHOTREXATE, MYCOPHENOLATE MOFETIL, PREDNISONE, RUXOLITINIB, TISLELIZUMAB, ZOPICLONE | DrugsGivenReaction | CC BY | 33868266 | 19,932,403 | 2021 |
What was the administration route of drug 'AZACITIDINE'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Subcutaneous | DrugAdministrationRoute | CC BY | 33868266 | 19,225,338 | 2021 |
What was the administration route of drug 'TISLELIZUMAB'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Intravenous (not otherwise specified) | DrugAdministrationRoute | CC BY | 33868266 | 19,225,338 | 2021 |
What was the dosage of drug 'BASILIXIMAB'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, UNKNOWN | DrugDosageText | CC BY | 33868266 | 19,932,403 | 2021 |
What was the dosage of drug 'CYCLOSPORINE'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, UNKNOWN | DrugDosageText | CC BY | 33868266 | 19,932,403 | 2021 |
What was the dosage of drug 'DOXORUBICIN'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, R-CHOP REGIMEN, 4 CYCLES | DrugDosageText | CC BY | 33868266 | 19,938,943 | 2021 |
What was the dosage of drug 'ESTAZOLAM'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, UNKNOWN | DrugDosageText | CC BY | 33868266 | 19,932,403 | 2021 |
What was the dosage of drug 'FLUDARABINE PHOSPHATE'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, FCR REGIMEN, 4 CYCLES | DrugDosageText | CC BY | 33868266 | 19,938,943 | 2021 |
What was the dosage of drug 'METHOTREXATE'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, UNKNOWN | DrugDosageText | CC BY | 33868266 | 19,932,403 | 2021 |
What was the dosage of drug 'MYCOPHENOLATE MOFETIL'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, UNKNOWN | DrugDosageText | CC BY | 33868266 | 19,932,403 | 2021 |
What was the dosage of drug 'PREDNISONE'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | 2 MILLIGRAM/KILOGRAM, Q24H | DrugDosageText | CC BY | 33868266 | 19,932,403 | 2021 |
What was the dosage of drug 'VINCRISTINE SULFATE'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, R-CHOP REGIMEN, 4 CYCLES | DrugDosageText | CC BY | 33868266 | 19,938,943 | 2021 |
What was the dosage of drug 'ZOPICLONE'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | UNK, UNKNOWN | DrugDosageText | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease in intestine'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Fatal | ReactionOutcome | CC BY | 33868266 | 19,938,943 | 2021 |
What was the outcome of reaction 'Acute graft versus host disease'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Fatal | ReactionOutcome | CC BY | 33868266 | 19,225,338 | 2021 |
What was the outcome of reaction 'Acute myeloid leukaemia'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Not recovered | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Adrenal insufficiency'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Recovering | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Autoimmune encephalopathy'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Not recovered | ReactionOutcome | CC BY | 33868266 | 19,225,338 | 2021 |
What was the outcome of reaction 'Chronic graft versus host disease in skin'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Recovering | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Death'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Fatal | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Diarrhoea infectious'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Not recovered | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Drug ineffective for unapproved indication'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Fatal | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Drug-induced liver injury'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Recovered | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Graft versus host disease'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Fatal | ReactionOutcome | CC BY | 33868266 | 19,222,652 | 2021 |
What was the outcome of reaction 'Haematochezia'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Not recovered | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Herpes zoster infection neurological'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Recovered | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Herpes zoster'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Recovered | ReactionOutcome | CC BY | 33868266 | 19,938,943 | 2021 |
What was the outcome of reaction 'Infection'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Not recovered | ReactionOutcome | CC BY | 33868266 | 19,225,338 | 2021 |
What was the outcome of reaction 'Metabolic acidosis'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Not recovered | ReactionOutcome | CC BY | 33868266 | 19,225,338 | 2021 |
What was the outcome of reaction 'Myelodysplastic syndrome'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Recovered | ReactionOutcome | CC BY | 33868266 | 19,911,523 | 2021 |
What was the outcome of reaction 'Product use in unapproved indication'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Fatal | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Pyrexia'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Recovering | ReactionOutcome | CC BY | 33868266 | 19,932,403 | 2021 |
What was the outcome of reaction 'Septic shock'? | Case Report: Combination Therapy With PD-1 Blockade for Acute Myeloid Leukemia After Allogeneic Hematopoietic Stem Cell Transplantation Resulted in Fatal GVHD.
Background: Azacitidine is commonly used in the treatment of relapsed acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS) after allogeneic hematopoi... | Not recovered | ReactionOutcome | CC BY | 33868266 | 19,225,338 | 2021 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Cardiac tamponade'. | Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction.
An 83-year-old man with a history of permanent atrial fibrillation (AF) anticoagulated by dabigatran 150 b.i.d., type 2 diabetes mellitus, and hypertension was admitted to the hospital... | IDARUCIZUMAB | DrugsGivenReaction | CC BY-NC-SA | 33868433 | 19,209,253 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Coronary artery dissection'. | Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction.
An 83-year-old man with a history of permanent atrial fibrillation (AF) anticoagulated by dabigatran 150 b.i.d., type 2 diabetes mellitus, and hypertension was admitted to the hospital... | DABIGATRAN ETEXILATE MESYLATE | DrugsGivenReaction | CC BY-NC-SA | 33868433 | 19,201,824 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Extravasation blood'. | Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction.
An 83-year-old man with a history of permanent atrial fibrillation (AF) anticoagulated by dabigatran 150 b.i.d., type 2 diabetes mellitus, and hypertension was admitted to the hospital... | DABIGATRAN ETEXILATE MESYLATE | DrugsGivenReaction | CC BY-NC-SA | 33868433 | 19,201,824 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Pericardial haemorrhage'. | Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction.
An 83-year-old man with a history of permanent atrial fibrillation (AF) anticoagulated by dabigatran 150 b.i.d., type 2 diabetes mellitus, and hypertension was admitted to the hospital... | DABIGATRAN ETEXILATE MESYLATE | DrugsGivenReaction | CC BY-NC-SA | 33868433 | 19,201,824 | 2021-03 |
Give an alphabetized list of all active substances of drugs taken by the patient who experienced 'Vascular procedure complication'. | Idarucizumab for dabigatran reversal in cardiac tamponade complicating percutaneous intervention in ST elevation myocardial infarction.
An 83-year-old man with a history of permanent atrial fibrillation (AF) anticoagulated by dabigatran 150 b.i.d., type 2 diabetes mellitus, and hypertension was admitted to the hospital... | DABIGATRAN ETEXILATE MESYLATE | DrugsGivenReaction | CC BY-NC-SA | 33868433 | 19,201,824 | 2021-03 |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.